EUVIMEDEUVIMED entdecken
Crossref

Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials

Craig H. Mallinckrodt, Peter W. Lane, Dan Schnell, Yahong Peng, James P. Mancuso

Drug Information Journal · 2008-07 · 42 (4) · 303-319

DOI: 10.1177/009286150804200402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Information Journal, online erschienen am 30.12.2008. Verfasst von Craig H. Mallinckrodt und 4 weiteren Autor:innen. Die Arbeit wurde bisher 303-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mallinckrodt, C. H., Lane, P. W., Schnell, D., Peng, Y., & Mancuso, J. P. (2008). Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials. Drug Information Journal, 42(4), 303-319. https://doi.org/10.1177/009286150804200402

Vancouver

Mallinckrodt CH, Lane PW, Schnell D, Peng Y, Mancuso JP. Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials. Drug Information Journal. 2008;42(4):303-319. doi:10.1177/009286150804200402

BibTeX
@article{Mallinckrodt2008,
  author = {Mallinckrodt, Craig H. and Lane, Peter W. and Schnell, Dan and Peng, Yahong and Mancuso, James P.},
  title = {Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials},
  journal = {Drug Information Journal},
  year = {2008},
  volume = {42},
  number = {4},
  pages = {303--319},
  doi = {10.1177/009286150804200402}
}
Kostenlos starten →